Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Remdesivir Approved by FDA Experimental Antiviral Oct/15/2020 Oct/23/2020 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Sep/25/2020 Oct/19/2020 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/22/2020 Oct/15/2020 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020 Oct/10/2020 0
Atazanavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/14/2020 Oct/05/2020 0
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/14/2020 Oct/05/2020 0
Daptomycin Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/07/2020 Sep/30/2020 0
Alarelin Potential treatment - theoretical effect Experimental Antiviral Sep/07/2020 Sep/30/2020 0